ORAMED PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $32.9M | $19.3M |
| FY2021 | — | $115.8M | $77.2M |
| FY2022 | $25.0K | $151.8M | $40.5M |
| FY2023 | — | $163.8M | $9.1M |
| FY2024 | — | $146.3M | $54.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $32.9M | $19.3M |
| FY2021 | — | $115.8M | $77.2M |
| FY2022 | $25.0K | $151.8M | $40.5M |
| FY2023 | — | $163.8M | $9.1M |
| FY2024 | — | $146.3M | $54.4M |